FIELD: medicine.
SUBSTANCE: invention relates to the field of ophthalmology, in particular to ophthalmo-oncology. Using polymerase chain reaction (PCR), genomic ctDNA with GENE/GNA11 mutations is determined in real time. In the presence of mutations in exon 4 and/or 5, a pigment-free melanoma is determined, and in the absence, delimited choroidal hemangioma.
EFFECT: invention provides an increase in the reliability of the study and the prevention of the development of secondary complications.
1 cl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR DETERMINING THE RISK OF TRANSFORMATION OF A STATIONARY CHOROIDAL NEVUS INTO A PROGRESSIVE NEVUS | 2020 |
|
RU2753889C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY UVEAL MELANOMA AND LOCALIZED CHOROIDAL HEMANGIOMA USING OPTICAL COHERENT TOMOGRAPHY-ANGIOGRAPHY | 2016 |
|
RU2622380C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF INITIAL CHOROID MELANOMA AND CHOROID NEVUS BY MEANS OF OPTICAL COHERENT TOMOGRAPHY WITH ANGIOGRAPHIC MODE | 2019 |
|
RU2705419C1 |
| METHOD FOR DETERMINING INDICATIONS FOR THE REPEATED DESTRUCTION OF THE INITIAL MELANOMA OF CHOROID | 2017 |
|
RU2665185C1 |
| METHOD OF PREDICTING THE SPREAD OF NEUROEPITHELIAL DETACHMENT WITH THE DEVELOPMENT OF ATROPHY OF THE PHOTORECEPTOR LAYER IN CHOROIDAL HEMANGIOMA | 2023 |
|
RU2804715C1 |
| METHOD OF DIAGNOSING INTRAOCULAR NEOPLASMS | 2008 |
|
RU2387378C1 |
| METHOD FOR APPLYING PHOTODYNAMIC INTRAOCULAR TUMOR THERAPY | 2006 |
|
RU2320382C1 |
| METHOD FOR DETERMINING DIFFERENTIATED INDICATIONS FOR TREATING A LIMITED HAEMANGIOMA OF A CHOROID | 2019 |
|
RU2698446C1 |
| METHOD FOR DIFFERENTIAL DIAGNOSIS OF PRIMARY MELANOMA AND CHOROID NEVUS | 2018 |
|
RU2689190C1 |
| METHOD OF COMBINED ONE-STAGE LASER TREATMENT OF SMALL-SIZED AMELANOTIC CHOROIDAL MELANOMA OF JUXTAPIPILLARY LOCALIZATION | 2023 |
|
RU2805827C1 |
